HHMI
TER icon

Howard Hughes Medical Institute’s Teradyne TER Stock Holding History

Howard Hughes Medical Institute’s Portfolio TER Stock Details TER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-34
Closed -$6.58K – 429
2025
Q4 		$6.58K Sell
34
-1
-3% -$172 ﹤0.01% 288
2025
Q3 		$4.82K Hold
35
– – ﹤0.01% 347
2025
Q2 		$3.15K Buy
+35
New +$2.8K ﹤0.01% 415
2013
Q4 		– Sell
-346
Closed -$6K – 206
2013
Q3 		$6K Sell
346
-169
-33% -$2.81K ﹤0.01% 195
2013
Q2 		$9K Buy
+515
New +$8.56K ﹤0.01% 200

Other funds holding TER

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Howard Hughes Medical Institute's TER Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Teradyne (TER) in Q1 2026, closing a stake of 34 shares — an estimated $6.58K sold.

Howard Hughes Medical Institute first reported a position in TER in Q2 2013 and held it in 5 quarters. The position peaked at $9K in Q2 2013. 1,224 funds tracked by Wall St. Rank hold TER as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Teradyne position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 34 Teradyne shares in Q1 2026, an estimated $6.58K.
  • Howard Hughes Medical Institute first reported a position in Teradyne in Q2 2013 and held it in 5 quarters.
  • Howard Hughes Medical Institute's Teradyne position peaked at $9K in Q2 2013.
  • 1,224 funds tracked by Wall St. Rank held Teradyne as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.